Meanwhile, we found that the plasma LIF or Gal3 levels of tumor-bearing mice were not affected by the exogenous NE treatment (Supplementary information, Fig. S8c), confirming that the release of LIF or Gal3 by cancer cells was independent of sympathetic signaling. The gene discussed is LGALS3; the disease is neoplasm.